Search results for " decision making"

showing 10 items of 183 documents

Why do house-hunting ants recruit in both directions?

2007

8 pages; International audience; To perform tasks, organisms often use multiple procedures. Explaining the breadth of such behavioural repertoires is not always straightforward. During house hunting, colonies of Temnothorax albipennis ants use a range of behaviours to organise their emigrations. In particular, the ants use tandem running to recruit na? ants to potential nest sites. Initially, they use forward tandem runs (FTRs) in which one leader takes a single follower along the route from the old nest to the new one. Later, they use reverse tandem runs (RTRs) in the opposite direction. Tandem runs are used to teach active ants the route between the nests, so that they can be involved qui…

0106 biological sciencesMESH: Decision MakingOperations researchTemnothorax albipennisMESH : Social BehaviorTandem runningSocial insectsMESH : Behavior Animal01 natural sciencesNesting BehaviorNestMESH : EcosystemMESH: Behavior Animal[ SDV.EE.IEO ] Life Sciences [q-bio]/Ecology environment/SymbiosisMESH: AnimalsMESH: EcosystemMESH: Nesting BehaviorRecruitment methodsMESH: Models Theoretical0303 health sciencesBehavior AnimalbiologyEcologyGeneral MedicineMESH : AntsCollective behaviourMESH: Social BehaviorTandem runningMESH: Population DensityDecision MakingMESH: AntsMESH : Nesting Behavior010603 evolutionary biology03 medical and health sciencesAnimalsTemnothorax albipennisMESH : Population DensitySocial BehaviorSet (psychology)EcosystemEcology Evolution Behavior and Systematics030304 developmental biologyPopulation DensityOriginal PaperAntsMESH : Models TheoreticalModels TheoreticalRecruitment methodsbiology.organism_classificationMESH : Decision MakingMESH : Animals[SDV.EE.IEO]Life Sciences [q-bio]/Ecology environment/Symbiosis
researchProduct

DESDEO: The Modular and Open Source Framework for Interactive Multiobjective Optimization

2021

Interactive multiobjective optimization methods incorporate preferences from a human decision maker in the optimization process iteratively. This allows the decision maker to focus on a subset of solutions, learn about the underlying trade-offs among the conflicting objective functions in the problem and adjust preferences during the solution process. Incorporating preference information allows computing only solutions that are interesting to the decision maker, decreasing computation time significantly. Thus, interactive methods have many strengths making them viable for various applications. However, there is a lack of existing software frameworks to apply and experiment with interactive …

0209 industrial biotechnologylineaarinen optimointiPareto optimizationGeneral Computer Sciencemulti-criteria decision makingComputer sciencepäätöksentekoevoluutiolaskenta02 engineering and technologyData-driven multiobjective optimizationcomputer.software_genrenonlinear optimizationMulti-objective optimizationData modelingopen source softwareavoin lähdekoodi020901 industrial engineering & automationSoftwareoptimointi0202 electrical engineering electronic engineering information engineeringGeneral Materials ScienceUse casecomputer.programming_languageGraphical user interfacepareto-tehokkuusbusiness.industryGeneral Engineeringinteractive methodsModular designPython (programming language)monitavoiteoptimointiTK1-9971Software frameworkdata-driven multiobjective optimizationevolutionary computation020201 artificial intelligence & image processingElectrical engineering. Electronics. Nuclear engineeringbusinessSoftware engineeringcomputerIEEE Access
researchProduct

Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit

2020

Ursodeoxycholic acid (UDCA) is a hydrophilic bile acid with an established benefit for patients suffering from primary biliary cholangitis (PBC). It was first introduced in the 60s and took until the late 90s to demonstrate a survival benefit in large meta-cohort studies.1 Since then, UDCA is the established first-line therapy according to current guidelines.2 The benefit of UDCA is multidimensional, and patients receiving UDCA experience increased transplant-free survival, a decreased risk of hepatocellular carcinoma and potentially improved quality of life.3–5 The survival benefit is predicted by a number biochemical markers that reflect cholestasis and that are accepted surrogates of the…

0301 basic medicineCholagogues and Cholereticsmedicine.medical_specialty2312Cholangitismedicine.drug_classBiliary cirrhosisclinical decision makingliverGastroenterologyhepatobiliary disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePrimary biliary cirrhosisCholestasisInternal medicinemedicineHumans1506BezafibrateHepatologyBile acidLiver Cirrhosis Biliarybusiness.industryUrsodeoxycholic AcidGastroenterologyObeticholic acidmedicine.diseaseUrsodeoxycholic acidLiver Transplantationprimary biliary cirrhosis030104 developmental biologychemistryHepatocellular carcinoma030211 gastroenterology & hepatologybusinessmedicine.drugGut
researchProduct

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients

2016

In the last 20 years, following the identification of the BRCA1 and BRCA2 genes (hereinafter referred to as the BRCA genes), preventive pathways have been developed for the identification and clinical management of individuals at high risk of developing breast and ovarian cancer due to the presence of a pathogenic variant in either of these genes. These pathways are aimed at educating high-risk subjects on programs targeted toward early diagnosis and cancer risk reduction. The approval of a novel class of drugs, the PARP enzyme inhibitors, for the treatment of ovarian cancer patients carrying high-risk BRCA pathogenic variants has changed this scenario. BRCA testing, in addition to providin…

0301 basic medicineOncologyCancer ResearchGenes BRCA2Genes BRCA1Brca testingBRCA1; BRCA2; genetic testing; germline mutations; ovarian cancer; PARP inhibitors; somatic mutations; Oncology; Cancer ResearchSettore MED/03 - GENETICA MEDICA0302 clinical medicineClinical decision makingInformed consentsomatic mutationBRCA1 BRCA2 genetic testing germline mutations somatic mutations ovarian cancer PARP inibitorsDisease management (health)PARP inhibitorsOvarian NeoplasmsTumorInformed Consentmedicine.diagnostic_testDisease ManagementGeneral MedicinePrognosisBRCA1; BRCA2; genetic testing; germline mutations; ovarian cancer; PARP inhibitors; somatic mutations; Biomarkers Tumor; Clinical Decision-Making; Disease Management; Female; Genes BRCA1; Genetic Variation; Germ-Line Mutation; Humans; Informed Consent; Mutation; Ovarian Neoplasms; Prognosis; Genes BRCA2; Genetic Testing; Oncology; Cancer Researchovarian cancergermline mutationOncology030220 oncology & carcinogenesisgermline mutationsFemaleHumanmedicine.medical_specialtyPrognosiClinical Decision-MakingMEDLINEgenetic testing03 medical and health sciencesPARP inibitorsInternal medicinemedicineBiomarkers TumorHumansGerm-Line MutationGenetic testingGynecologyBRCA1; BRCA2; PARP inhibitors; genetic testing; germline mutations; ovarian cancer; somatic mutationsbusiness.industryOvarian NeoplasmGenetic Variationmedicine.diseaseBRCA1BRCA2030104 developmental biologyPARP inhibitorGenesMutationsomatic mutationsOvarian cancerbusinessBiomarkers
researchProduct

Liquid Biopsy in Gastrointestinal Stromal Tumor

2017

Over the past 15 years, gastrointestinal stromal tumors (GISTs) have emerged from a poorly understood neoplasm to a well-defined tumor entity. Starting from 2000, the discovery of gain-of-function mutations involving KIT or PDGFRα (platelet-derived growth factor-α) genes and the development of tyrosine kinase inhibitors (TKIs), such as imatinib, revolutionized dramatically the management of GISTs. Due to the almost continual emergence of new data about biological complexity of GISTs and more sophisticated whole-genome technologies, to date, the role of molecular biology is clinically important to drive therapeutic decision making.

0301 basic medicinemedicine.medical_specialtyStromal cellbusiness.industryGeneral surgeryImatinibTherapeutic decision makingmedicine.diseasedigestive system diseases03 medical and health sciences030104 developmental biology0302 clinical medicine030220 oncology & carcinogenesisCancer researchMedicineNeoplasmGastrointestinal stromal tumors (GISTs)Liquid biopsyStromal tumorbusinessneoplasmsTyrosine kinasemedicine.drug
researchProduct

Building a statistical surveillance dashboard for COVID-19 infection worldwide

2020

When a pandemic like the current novel coronavirus (COVID-19) breaks out, it is important that authorities, healthcare organizations and official decision makers, have in place an effective monitoring system to promptly analyze data, create new insights into problematic areas and generate actionable knowledge for fact-based decision making. The aim of this article is to describe an initial work focused on building a comprehensive statistical surveillance dashboard for the epidemic of COVID-19, which can be exploited also for future needs. We propose novel ways of exploring, analyzing and presenting data, using metrics that have not been used previously. We also show the steps necessary to b…

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Dashboard (business)0211 other engineering and technologies02 engineering and technology01 natural sciencesIndustrial and Manufacturing Engineering010104 statistics & probabilitymultiple attribute decision-makingprocess monitoringPandemicHealth carestatistical process control0101 mathematicsSafety Risk Reliability and Quality021103 operations researchbusiness.industrySettore SECS-S/02 - Statistica Per La Ricerca Sperimentale E Tecnologicastatistical decision makingPublic relationsStatistical thinkingstatistical thinkingBusinessDecision analysisDecision analysiQuality Engineering
researchProduct

Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women…

2016

PURPOSE: The 21-gene Recurrence Score assay (Oncotype DX) provides prognostic/predictive information in oestrogen receptor positive (ER+) early breast cancer, but access/reimbursement has been limited in most European countries in the absence of prospective outcome data. Recently, two large prospective studies and a real-life 5-year outcome study have been reported. We performed a pooled analysis of prospective European impact studies to generate robust data on impact of use in different clinical subgroups. METHODS: The analysis included four studies (French, German, Spanish, and British) in ER+ human epidermal growth factor receptor 2-negative breast cancer patients (n = 527). Node-positiv…

Adult0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyReceptor ErbB-2medicine.medical_treatmentClinical Decision-MakingBreast NeoplasmsMama -- Càncer -- TractamentRisk AssessmentSeverity of Illness Index03 medical and health sciencesBreast cancer0302 clinical medicineBreast cancerInternal medicineQuimioteràpiaHumansMedicineProspective StudiesOestrogen receptorPrecision MedicineStage (cooking)Prospective cohort studyReimbursementAgedAged 80 and overGynecologyChemotherapyIndividualised medicinemedicine.diagnostic_testbusiness.industryGene Expression ProfilingMiddle Agedmedicine.diseaseTumor BurdenAdjuvant chemotherapyEurope030104 developmental biologyReceptors EstrogenOncology030220 oncology & carcinogenesisHormonal therapyFemaleNeoplasm Recurrence LocalbusinessOncotype DXClinical decision makingEuropean Journal of Cancer
researchProduct

Decision-Making Skills Moderate the Relationship between Psychological and Physical Pain with Suicidal Behavior in Depressed Patients

2019

International audience

AdultMale050103 clinical psychologyAdolescentDecision MakingMEDLINEPainSuicide AttemptedYoung Adult03 medical and health sciences[SCCO]Cognitive science0302 clinical medicineHumansMedicine0501 psychology and cognitive sciencesYoung adultApplied PsychologyComputingMilieux_MISCELLANEOUSAged[SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behaviorDepressionbusiness.industry05 social sciencesGeneral MedicineMiddle Aged16. Peace & justice030227 psychiatryPsychiatry and Mental healthClinical PsychologySuicidal behaviorPain psychologyFemalebusinessClinical psychologyMESH: Decision making; Depression/psychology; Pain/psychology; Suicide Attempt/psychology; Young Adult
researchProduct

Sexism Interacts with Patient–Physician Gender Concordance in Influencing Patient Control Preferences: Findings from a Vignette Experimental Design

2020

Background: Patient preferences regarding their involvement in shared treatments decisions is fundamental in clinical practice. Previous evidences demonstrated a large heterogeneity in these preferences. However, only few studies have analysed the influence of patients’ individual differences, contextual and situational qualities, and their complex interaction in explaining this variability. Methods: We assessed the role of the interaction of patient’s sociodemographic and psychological factors with a physician’s gender. Specifically, we focused on patient gender and attitudes toward male or female physicians. One hundred fifty-three people participated in this randomised controlled study a…

AdultMaleAdolescentConcordanceControl (management)shared decision making050109 social psychologypatient-centered care03 medical and health sciencesYoung AdultSex FactorsSettore M-PSI/01 - PSICOLOGIA GENERALEHumans0501 psychology and cognitive sciencesIn patientSituational ethicscontrol preferencescontrol preferences gender differences patient-centered care sexism shared decision makingApplied PsychologyAgedPhysician-Patient Relations030505 public health05 social sciencesPatient PreferenceOriginal ArticlesMiddle AgedPatient preferenceClinical PracticeVignettePhysician genderResearch Designgender differencesgender differencecontrol preferenceFemaleOriginal ArticlesexismPatient Participation0305 other medical sciencePsychologyClinical psychology
researchProduct

Does access to care play a role in liver cancer survival? The ten-year (2006–2015) experience from a population-based cancer registry in Southern Ita…

2021

Abstract Background Hepatocellular carcinoma (HCC) is the most frequent primary invasive cancer of the liver. During the last decade, the epidemiology of HCC has been continuously changing in developed countries, due to more effective primary prevention and to successful treatment of virus-related liver diseases. The study aims to examine survival by level of access to care in patients with HCC, for all patients combined and by age. Methods We included 2018 adult patients (15–99 years) diagnosed with a primary liver tumour, registered in the Palermo Province Cancer Registry during 2006–2015, and followed-up to 30 October 2019. We obtained a proxy measure of access to care by linking each re…

AdultMaleCancer Researchmedicine.medical_specialtyCarcinoma HepatocellularAdolescentContext (language use)access to care cancer registries liver cancer public health survival Adolescent AdultAge Distribution Aged Aged 80 and over Carcinoma Hepatocellular Decision Making Organizational Decision Support Techniques Female Follow-Up Studies Health Services Accessibility Health Services Needs and Demand Humans Italy Liver Neoplasms Male Middle Aged Registries Survival Analysis Young AdultSettore MED/42 - Igiene Generale E Applicatalcsh:RC254-282survivalHealth Services AccessibilityDecision Support Techniquesliver cancerYoung AdultAge DistributionInternal medicineHealth careEpidemiologyGeneticsmedicineHumansRegistriesDecision Making OrganizationalAgedAged 80 and overaccess to careHealth Services Needs and Demandbusiness.industryPublic healthLiver Neoplasmspublic healthMiddle Agedlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseSurvival AnalysisCancer registryItalyOncologycancer registriesHepatocellular carcinomaAmbulatoryFemaleLiver cancerbusinessFollow-Up StudiesResearch ArticleBMC Cancer
researchProduct